- Home
- XOMAP vs MANH Comparison
XOMAP vs MANH Comparison
Compare XOMAP & MANH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMAP
- MANH
- Stock Information
- Founded
- XOMAP N/A
- MANH 1990
- Country
- XOMAP United States
- MANH United States
- Employees
- XOMAP 13
- MANH N/A
- Industry
- XOMAP Biotechnology: Pharmaceutical Preparations
- MANH Computer Software: Prepackaged Software
- Sector
- XOMAP Health Care
- MANH Technology
- Exchange
- XOMAP Nasdaq
- MANH Nasdaq
- Market Cap
- XOMAP N/A
- MANH 17.2B
- IPO Year
- XOMAP N/A
- MANH 1998
- Fundamental
- Price
- XOMAP $26.47
- MANH $292.32
- Analyst Decision
- XOMAP
- MANH Strong Buy
- Analyst Count
- XOMAP 0
- MANH 8
- Target Price
- XOMAP N/A
- MANH $275.75
- AVG Volume (30 Days)
- XOMAP N/A
- MANH 400.4K
- Earning Date
- XOMAP N/A
- MANH 10-22-2024
- Dividend Yield
- XOMAP N/A
- MANH N/A
- EPS Growth
- XOMAP N/A
- MANH 42.01
- EPS
- XOMAP N/A
- MANH 3.28
- Revenue
- XOMAP N/A
- MANH $996,566,000.00
- Revenue This Year
- XOMAP N/A
- MANH $14.35
- Revenue Next Year
- XOMAP N/A
- MANH $11.02
- P/E Ratio
- XOMAP N/A
- MANH $89.13
- Revenue Growth
- XOMAP N/A
- MANH 17.49
- 52 Week Low
- XOMAP N/A
- MANH $182.97
- 52 Week High
- XOMAP N/A
- MANH $307.50
- Technical
- Relative Strength Index (RSI)
- XOMAP 64.62
- MANH 56.51
- Support Level
- XOMAP $26.24
- MANH $300.76
- Resistance Level
- XOMAP $26.48
- MANH $306.40
- Average True Range (ATR)
- XOMAP 0.14
- MANH 5.39
- MACD
- XOMAP 0.03
- MANH -0.57
- Stochastic Oscillator
- XOMAP 99.03
- MANH 50.70
About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
About MANH Manhattan Associates Inc.
Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.